Literature DB >> 33948853

Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.

Aiysha Abid1.   

Abstract

Primary hyperoxaluria type-III is a disorder of glyoxylate metabolism, caused by pathogenic variants in the HOGA1 gene. To date more than 50 disease-associated pathogenic sequence variants are identified in the gene. A few of the variants are population specific and are considered to have a founder effect in respective populations. The most prevalent variant, c.700+5G>T, identified frequently in Caucasian (allele frequency 0.63) and European (0.35) populations. Two variants, c.860G>T (p.Gly287Val) and c.944_946delAGG (p.Glu315del), account for 95% of the allele count in patients of Ashkenazi Jews ancestry. A possible mutational hot-spot at c.834 position is frequently found mutated in Chinese patients. This observed ethnic associations of HOGA1 alleles span a spectrum ranging from recurrence limited to an ethnic group to a possible founder-effect.

Entities:  

Year:  2021        PMID: 33948853     DOI: 10.1007/s11033-021-06380-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

1.  Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

Authors:  Ada Ventzke; Markus Feldkötter; Andrew Wei; Jutta Becker; Bodo B Beck; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2017-07-15       Impact factor: 3.714

2.  Renal function can be impaired in children with primary hyperoxaluria type 3.

Authors:  Lise Allard; Pierre Cochat; Anne-Laure Leclerc; François Cachat; Christine Fichtner; Vandréa Carla De Souza; Clotilde Druck Garcia; Marie-Christine Camoin-Schweitzer; Marie-Alice Macher; Cécile Acquaviva-Bourdain; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2015-05-14       Impact factor: 3.714

3.  Late diagnosis of primary hyperoxaluria type III.

Authors:  Emmanuel Richard; Jean-Marc Blouin; Jérome Harambat; Brigitte Llanas; Stéphane Bouchet; Cécile Acquaviva; Renaud de la Faille
Journal:  Ann Clin Biochem       Date:  2017-01-10       Impact factor: 2.057

4.  Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.

Authors:  Xiaoliang Fang; Lei He; Guofeng Xu; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Pediatr Nephrol       Date:  2019-05-23       Impact factor: 3.714

5.  The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.

Authors:  Emma L Williams; Detlef Bockenhauer; William G van't Hoff; Nikhil Johri; Chris Laing; Manish D Sinha; Robert Unwin; Adie Viljoen; Gill Rumsby
Journal:  Nephrol Dial Transplant       Date:  2012-03-05       Impact factor: 5.992

6.  [A review of 53 cases of distal tubal microsurgery (author's transl)].

Authors:  J B Dubuisson; J Barbot; F Aubriot; R Henrion
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1981

7.  Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.

Authors:  Bodo B Beck; Anne Baasner; Anja Buescher; Sandra Habbig; Nadine Reintjes; Markus J Kemper; Przemyslaw Sikora; Christoph Mache; Martin Pohl; Mirjam Stahl; Burkhard Toenshoff; Lars Pape; Henry Fehrenbach; Dorrit E Jacob; Bernd Grohe; Matthias T Wolf; Gudrun Nürnberg; Gökhan Yigit; Eduardo C Salido; Bernd Hoppe
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

8.  Mutations in DHDPSL are responsible for primary hyperoxaluria type III.

Authors:  Ruth Belostotsky; Eric Seboun; Gregory H Idelson; Dawn S Milliner; Rachel Becker-Cohen; Choni Rinat; Carla G Monico; Sofia Feinstein; Efrat Ben-Shalom; Daniella Magen; Irith Weissman; Celine Charon; Yaacov Frishberg
Journal:  Am J Hum Genet       Date:  2010-09-10       Impact factor: 11.025

9.  Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

Authors:  Carla G Monico; Sandro Rossetti; Ruth Belostotsky; Andrea G Cogal; Regina M Herges; Barbara M Seide; Julie B Olson; Eric J Bergstrahl; Hugh J Williams; William E Haley; Yaacov Frishberg; Dawn S Milliner
Journal:  Clin J Am Soc Nephrol       Date:  2011-09       Impact factor: 8.237

10.  Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing.

Authors:  Emma L Williams; Eleanor A L Bagg; Michael Mueller; Jana Vandrovcova; Timothy J Aitman; Gill Rumsby
Journal:  Mol Genet Genomic Med       Date:  2015-01       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.